Univariate analysis using age, body mass index, clinical T stage (T1c or ≥T2a), PSA, prostate volume, number of biopsy cores, type of anesthesia, previous biopsy history, and the presence of prostate cancer were used to construct a model. This evidence concerns the gene KLK3 and prostate carcinoma.